Functions: The study demonstrates that loss of p53 promotes neuron reprogramming in head and neck cancer cells, potentially enhancing tumor plasticity and progression.Unsolved: The research may leave unresolved questions regarding the precise molecular mechanisms of neuron reprogramming and its therapeutic targeting in clinical settings. Here, TP53 is linked to neoplasm.